##gff-version 3
##sequence-region P32245 1 332
P32245	UniProtKB	Chain	1	332	.	.	.	ID=PRO_0000069722;Note=Melanocortin receptor 4	
P32245	UniProtKB	Topological domain	1	43	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Transmembrane	44	69	.	.	.	Note=Helical%3B Name%3D1;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Topological domain	70	81	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Transmembrane	82	106	.	.	.	Note=Helical%3B Name%3D2;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Topological domain	107	123	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Transmembrane	124	145	.	.	.	Note=Helical%3B Name%3D3;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Topological domain	146	165	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Transmembrane	166	186	.	.	.	Note=Helical%3B Name%3D4;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Topological domain	187	191	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Transmembrane	192	215	.	.	.	Note=Helical%3B Name%3D5;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Topological domain	216	248	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Transmembrane	249	271	.	.	.	Note=Helical%3B Name%3D6;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Topological domain	272	280	.	.	.	Note=Extracellular;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Transmembrane	281	304	.	.	.	Note=Helical%3B Name%3D7;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Topological domain	305	332	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Lipidation	318	318	.	.	.	Note=S-palmitoyl cysteine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Glycosylation	3	3	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Glycosylation	17	17	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Glycosylation	26	26	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P32245	UniProtKB	Disulfide bond	84	84	.	.	.	Note=Interchain	
P32245	UniProtKB	Natural variant	11	11	.	.	.	ID=VAR_038632;Note=In obesity%3B partial activity. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12646665;Dbxref=dbSNP:rs372794914,PMID:12646665	
P32245	UniProtKB	Natural variant	30	30	.	.	.	ID=VAR_010704;Note=In obesity. S->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10199800;Dbxref=dbSNP:rs13447323,PMID:10199800	
P32245	UniProtKB	Natural variant	36	36	.	.	.	ID=VAR_038633;Note=In obesity%3B shows the same affinity as the wild-type but significant impairment of cAMP-induced activity in response to melanotan II compared with the wild-type receptor. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15486053;Dbxref=PMID:15486053	
P32245	UniProtKB	Natural variant	37	37	.	.	.	ID=VAR_010705;Note=In obesity. D->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10199800;Dbxref=dbSNP:rs13447325,PMID:10199800	
P32245	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_038634;Note=In obesity. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11487744;Dbxref=dbSNP:rs121913557,PMID:11487744	
P32245	UniProtKB	Natural variant	58	58	.	.	.	ID=VAR_038635;Note=In obesity. S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11487744;Dbxref=dbSNP:rs121913558,PMID:11487744	
P32245	UniProtKB	Natural variant	62	62	.	.	.	ID=VAR_038636;Note=In obesity%3B shows a partial cAMP response to alpha-MSH. N->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12588803,ECO:0000269|PubMed:12646665;Dbxref=dbSNP:rs121913566,PMID:12588803,PMID:12646665	
P32245	UniProtKB	Natural variant	72	72	.	.	.	ID=VAR_077570;Note=Probable disease-associated mutation found in a patient with early onset obesity and hyperphagia%3B loss of plasma membrane localization%3B loss of receptor function. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25163632;Dbxref=PMID:25163632	
P32245	UniProtKB	Natural variant	78	78	.	.	.	ID=VAR_010706;Note=In obesity. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10199800;Dbxref=dbSNP:rs13447326,PMID:10199800	
P32245	UniProtKB	Natural variant	88	92	.	.	.	ID=VAR_038637;Note=In obesity%3B the mutant receptor is expressed well on the cell surface but is completely devoid of ligand binding and cAMP generation in response to agonist stimulation. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14671178;Dbxref=PMID:14671178	
P32245	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_038638;Note=In obesity%3B completely unable to generate cAMP in response to ligand%3B shows evidence of impaired cell surface expression. N->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12588803,ECO:0000269|PubMed:12646665;Dbxref=dbSNP:rs121913565,PMID:12588803,PMID:12646665	
P32245	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_038639;Note=In obesity%3B shows the same affinity as the wild-type but significant impairment of cAMP-induced activity in response to melanotan II compared with the wild-type receptor. I->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11487744;Dbxref=dbSNP:rs121913559,PMID:11487744	
P32245	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_038640;Note=In obesity. I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15486053;Dbxref=dbSNP:rs121913559,PMID:15486053	
P32245	UniProtKB	Natural variant	103	103	.	.	.	ID=VAR_010707;Note=V->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11487744,ECO:0000269|PubMed:12646665,ECO:0000269|PubMed:14764818,ECO:0000269|PubMed:15486053,ECO:0000269|PubMed:7854347,ECO:0000269|PubMed:8392067;Dbxref=dbSNP:rs2229616,PMID:11487744,PMID:12646665,PMID:14764818,PMID:15486053,PMID:7854347,PMID:8392067	
P32245	UniProtKB	Natural variant	106	106	.	.	.	ID=VAR_038641;Note=In obesity%3B completely unable to generate cAMP in response to ligand%3B shows evidence of impaired cell surface expression. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12588803;Dbxref=PMID:12588803	
P32245	UniProtKB	Natural variant	112	112	.	.	.	ID=VAR_010708;Note=Polymorphism%3B no effect on MC4R signaling. T->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10199800,ECO:0000269|PubMed:12646665,ECO:0000269|PubMed:14764818,ECO:0000269|PubMed:15486053;Dbxref=dbSNP:rs13447329,PMID:10199800,PMID:12646665,PMID:14764818,PMID:15486053	
P32245	UniProtKB	Natural variant	125	125	.	.	.	ID=VAR_038642;Note=In obesity%3B completely unable to generate cAMP in response to ligand%3B shows evidence of impaired cell surface expression. I->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12588803,ECO:0000269|PubMed:12646665;Dbxref=PMID:12588803,PMID:12646665	
P32245	UniProtKB	Natural variant	127	127	.	.	.	ID=VAR_038643;Note=In obesity%3B signaling properties in response to alpha-MSH%2C beta-MSH and gamma-1-MSH are impaired. S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14764818;Dbxref=dbSNP:rs13447331,PMID:14764818	
P32245	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_038644;Note=In obesity%3B shows a partial cAMP response to alpha-MSH. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12588803,ECO:0000269|PubMed:12646665,ECO:0000269|PubMed:15486053;Dbxref=dbSNP:rs13447332,PMID:12588803,PMID:12646665,PMID:15486053	
P32245	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_010709;Note=In obesity. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10199800;Dbxref=dbSNP:rs13447332,PMID:10199800	
P32245	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_038645;Note=In obesity. I->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11487744;Dbxref=dbSNP:rs121913560,PMID:11487744	
P32245	UniProtKB	Natural variant	175	175	.	.	.	ID=VAR_038646;Note=In obesity%3B shows a partial cAMP response to alpha-MSH. A->T;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12588803,ECO:0000269|PubMed:12646665,ECO:0000269|PubMed:15486053;Dbxref=dbSNP:rs121913563,PMID:12588803,PMID:12646665,PMID:15486053	
P32245	UniProtKB	Natural variant	181	181	.	.	.	ID=VAR_038647;Note=In obesity%3B does not bind alpha-MSH. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15486053;Dbxref=dbSNP:rs13447333,PMID:15486053	
P32245	UniProtKB	Natural variant	219	219	.	.	.	ID=VAR_038648;Note=In obesity%3B shows significantly impairment of cAMP-induced activity in response to melanotan II compared with the wild-type receptor. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15486053;Dbxref=dbSNP:rs121913567,PMID:15486053	
P32245	UniProtKB	Natural variant	226	226	.	.	.	ID=VAR_038649;Note=I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14764818;Dbxref=dbSNP:rs193922686,PMID:14764818	
P32245	UniProtKB	Natural variant	251	251	.	.	.	ID=VAR_010710;Note=I->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10199800,ECO:0000269|PubMed:11487744,ECO:0000269|PubMed:12646665,ECO:0000269|PubMed:14764818,ECO:0000269|PubMed:15486053;Dbxref=dbSNP:rs52820871,PMID:10199800,PMID:11487744,PMID:12646665,PMID:14764818,PMID:15486053	
P32245	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_010711;Note=In obesity. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10199800;Dbxref=dbSNP:rs13447336,PMID:10199800	
P32245	UniProtKB	Natural variant	253	253	.	.	.	ID=VAR_038650;Note=In obesity%3B shows a partial cAMP response to alpha-MSH. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12588803;Dbxref=dbSNP:rs187152753,PMID:12588803	
P32245	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_038651;Note=In obesity%3B completely unable to generate cAMP in response to ligand%3B shows impaired cell surface expression. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12646665;Dbxref=dbSNP:rs1057517991,PMID:12646665	
P32245	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_038652;Note=In obesity%3B no activity. C->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12588803,ECO:0000269|PubMed:12646665;Dbxref=dbSNP:rs121913562,PMID:12588803,PMID:12646665	
P32245	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_015357;Note=In obesity. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11443223;Dbxref=dbSNP:rs121913561,PMID:11443223	
P32245	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_038653;Note=In obesity%3B shows reduced cAMP response to alpha-MSH%3B retains normal affinity for the antagonist AGRP. I->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12588803,ECO:0000269|PubMed:12646665;Dbxref=dbSNP:rs121913564,PMID:12588803,PMID:12646665	
P32245	UniProtKB	Natural variant	317	317	.	.	.	ID=VAR_010712;Note=In obesity. I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10199800;Dbxref=dbSNP:rs13447337,PMID:10199800	
P32245	UniProtKB	Natural variant	325	325	.	.	.	ID=VAR_038654;Note=In obesity%3B does not bind alpha-MSH. L->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15486053;Dbxref=PMID:15486053	
P32245	UniProtKB	Sequence conflict	169	169	.	.	.	Note=I->S;Ontology_term=ECO:0000305;evidence=ECO:0000305	
